ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
CAR-T cell therapy modifies T-cells to target cancer, offering an alternative for patients with non-responsive immune systems. The therapy can potentially clear tumors with one treatment and remain in ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.